Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Regeneron Pharmaceutical (NASDAQ: REGN)

$370.12 USD -$6.28 (-1.67%)
Last Price $370.12
Net Change $-6.28 (-1.67%)
Bid $0
Ask Price $0
Open Price $376.4
Previous Close Price $376.4
High Price $379.2
Low Price $368.81
Number of Trades 3,602
Volume 640,200
Fifty Two Week High $452.96 (2016-11-14)
Fifty Two Week Low $325.35 (2016-11-04)
Average Daily Volume 944,546
Share Outstanding 106,080 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $3.04 (2017-02-09)
2nd Quarter Earnings $3.13 (2016-11-04)
3nd Quarter Earnings $2.82 (2016-08-04)
4th Quarter Earnings $2.57 (2016-05-05)
PE Ratio $46.13
EPS Growth $23
Recent Earnings $3.04
Annual EPS $8.16
Last Quarter EPS $
Market Capitalization $39.26B
Insider Shareholders % 0.104%
Annual Revenue $0B
No. Shares Outstanding 106,080
Inst. Shareholder % 67.53%
Annual Net Income $0B
TTM Net Profit Margin $146.22
1-Year Return -8.47%
3-Year Return 22.12%
5-Year Return 193.05%
5-Year Revenue Growth 990.22%
5-Year Earnings Growth -442.74%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 23%
Dividends per Share $
Stock Split Ratio
Beta 1.34
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)